Midday movers: Lululemon, Paramount and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
bluebird bio (BLUE) shares rally as Morgan Stanley believes lovo-cel likely to be approved by December PDUFA date
December 8, 2023 10:20 AM ESTbluebird bio (NASDAQ: BLUE) shares jumped Friday after Morgan Stanley analyst Jeffrey Hung raised the stock to Equal-Weight from Underweight, lifting the price target to $7 from $3 per share.
BLUE shares are up more than 11% at the time of writing, trading at around... More
